Be the first person to write a business review for DENTSPLY Limited

DePuy makes it possible for orthopedic patients to stand up straight and take a step in the right direction. A subsidiary of Johnson & Johnson, DePuy's businesses develop and market orthopedic joint reconstruction, spinal care products, and neurosurgical devices. As one of the world's largest suppliers of orthopedic products, DePuy's products include hip replacements; knee, shoulder, and spinal implants; internal and external fixator products for bone fractures; and operating room equipment and supplies. The company's products are used primarily by orthopedic specialists and neurosurgeons to treat patients with musculoskeletal defects resulting from diseases, deformities, trauma, or accidents.

Founded in 1895, DePuy Orthopaedics was the first commercial orthopaedics company in the U.S. That pioneering spirit is still what drives the company today. The company's long-standing commitment to innovation in patient care has helped the company become a global leader in orthopaedic devices and supplies, including hip, knee, extremity, trauma, cement and operating room products.

DeRoyal Industries,Inc. makes medical equipment and surgical supplies. Products include orthopedic and rehabilitation products, wound care dressings, and surgical safety and critical care products. Its surgical and acute care product lines include custom procedural trays, anesthesia and temperature monitoring supplies, birthing and neonatal care items, catheterization supplies, and endoscopy products, as well as systems devoted to the disposal of medical waste. DeRoyal also has the ability to handle contract manufacturing for those inside and outside the medical industry. The company is owned by chairman and founder Pete DeBusk.

Devax, Inc., a medical device company focused on developing next generation products for interventional cardiology, today announced that the Company has completed patient enrollment in the DIVERGE clinical trial evaluating its novel AXXESS™ Bifurcation Stent System. The DIVERGE trial, a prospective, multi-center trial which enrolled 302 patients, is the largest study conducted to date with a drug-eluting stent specifically designed for treating bifurcation lesions.

Diapulse® Corporation of America is the pioneer and leader in the biophysical therapeutic effects of non-thermal pulsed electromagnetic energy in medicine. The Company manufacturers, researches and develops the proprietary Diapulse® medical technology. It is indicated for the adjunctive use in the palliative treatment of postoperative edema and pain in superficial soft tissues in acute and chronic wounds.Diapulse® is Medicare Covered to treat Stage III and IV pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in Hospitals, Nursing Homes, Therapy Clinics and Physician Offices.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.